Fortress Biotech Pref Preferred Stock Price Prediction
| FBIOP Preferred Stock | USD 12.63 0.08 0.63% |
Momentum 67
Buy Stretched
Oversold | Overbought |
Using Fortress Biotech hype-based prediction, you can estimate the value of Fortress Biotech Pref from the perspective of Fortress Biotech response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Fortress Biotech to buy its preferred stock at a price that has no basis in reality. In that case, they are not buying Fortress because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell preferred stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Fortress Biotech after-hype prediction price | USD 12.63 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as preferred stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Fortress |
Fortress Biotech After-Hype Price Density Analysis
As far as predicting the price of Fortress Biotech at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Fortress Biotech or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Preferred Stock prices, such as prices of Fortress Biotech, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Fortress Biotech Estimiated After-Hype Price Volatility
In the context of predicting Fortress Biotech's preferred stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Fortress Biotech's historical news coverage. Fortress Biotech's after-hype downside and upside margins for the prediction period are 7.77 and 17.49, respectively. We have considered Fortress Biotech's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Fortress Biotech is somewhat reliable at this time. Analysis and calculation of next after-hype price of Fortress Biotech Pref is based on 3 months time horizon.
Fortress Biotech Preferred Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Fortress Biotech is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Fortress Biotech backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Preferred Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Fortress Biotech, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
1.08 | 4.86 | 0.00 | 0.05 | 0 Events / Month | 4 Events / Month | In a few days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
12.63 | 12.63 | 0.00 |
|
Fortress Biotech Hype Timeline
Fortress Biotech Pref is currently traded for 12.63. The entity stock is not elastic to its hype. The average elasticity to hype of competition is -0.05. Fortress is estimated not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is estimated to be very small, whereas the daily expected return is currently at 1.08%. %. The volatility of related hype on Fortress Biotech is about 10800.0%, with the expected price after the next announcement by competition of 12.58. The company recorded a loss per share of 0.86. Fortress Biotech Pref last dividend was issued on the 14th of February 2023. Assuming the 90 days horizon the next estimated press release will be in a few days. Check out Fortress Biotech Basic Forecasting Models to cross-verify your projections. To learn how to invest in Fortress Preferred Stock, please use our How to Invest in Fortress Biotech guide.Fortress Biotech Related Hype Analysis
Having access to credible news sources related to Fortress Biotech's direct competition is more important than ever and may enhance your ability to predict Fortress Biotech's future price movements. Getting to know how Fortress Biotech's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Fortress Biotech may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| EQ | Equillium | 0.39 | 8 per month | 6.72 | 0.01 | 19.26 | (12.50) | 43.07 | |
| COEP | Coeptis Therapeutics | (0.48) | 6 per month | 0.00 | (0.03) | 7.44 | (6.12) | 22.14 | |
| IPSC | Century Therapeutics | 0.00 | 0 per month | 4.69 | 0.28 | 13.95 | (8.26) | 55.97 | |
| CUE | Cue Biopharma | 0.39 | 11 per month | 0.00 | (0.11) | 11.11 | (12.50) | 50.98 | |
| VTVT | vTv Therapeutics | 0.39 | 4 per month | 4.52 | 0.17 | 7.57 | (6.90) | 24.90 | |
| SNTI | Senti Biosciences | (0.09) | 9 per month | 0.00 | (0.12) | 7.73 | (9.50) | 53.50 | |
| GNTA | Genenta Science SpA | 0.01 | 9 per month | 0.00 | (0.17) | 6.47 | (10.16) | 39.96 | |
| NRXP | NRX Pharmaceuticals | (0.53) | 2 per month | 0.00 | (0.1) | 7.34 | (8.02) | 21.29 | |
| JUNS | Jupiter Neurosciences Common | 0.00 | 0 per month | 0.00 | (0.23) | 4.65 | (7.69) | 21.70 | |
| TELO | Telomir Pharmaceuticals Common | (0.53) | 2 per month | 0.00 | (0.07) | 4.00 | (4.93) | 15.51 |
Fortress Biotech Additional Predictive Modules
Most predictive techniques to examine Fortress price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Fortress using various technical indicators. When you analyze Fortress charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Fortress Biotech Predictive Indicators
The successful prediction of Fortress Biotech stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Fortress Biotech Pref, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Fortress Biotech based on analysis of Fortress Biotech hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Fortress Biotech's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Fortress Biotech's related companies.
Pair Trading with Fortress Biotech
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Fortress Biotech position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Fortress Biotech will appreciate offsetting losses from the drop in the long position's value.Moving together with Fortress Preferred Stock
| 0.62 | MUFG | Mitsubishi UFJ Financial Sell-off Trend | PairCorr |
| 0.87 | SMFNF | Sumitomo Mitsui Financial Earnings Call This Week | PairCorr |
Moving against Fortress Preferred Stock
The ability to find closely correlated positions to Fortress Biotech could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Fortress Biotech when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Fortress Biotech - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Fortress Biotech Pref to buy it.
The correlation of Fortress Biotech is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Fortress Biotech moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Fortress Biotech Pref moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Fortress Biotech can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for Fortress Preferred Stock Analysis
When running Fortress Biotech's price analysis, check to measure Fortress Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Fortress Biotech is operating at the current time. Most of Fortress Biotech's value examination focuses on studying past and present price action to predict the probability of Fortress Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Fortress Biotech's price. Additionally, you may evaluate how the addition of Fortress Biotech to your portfolios can decrease your overall portfolio volatility.